Viewing StudyNCT00024115



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00024115
Status: WITHDRAWN
Last Update Posted: 2015-04-28
First Post: 2001-09-13

Brief Title: BL22 Immunotoxin in Treating Patients With Non-Hodgkins Lymphoma or Chronic Lymphocytic Leukemia
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Leukemia
Keywords:
Name View
recurrent mantle cell lymphoma View
refractory chronic lymphocytic leukemia View
B-cell chronic lymphocytic leukemia View
stage III grade I follicular small cleaved cell lymphoma View
stage III grade II follicular mixed cell lymphoma View
stage III adult diffuse small cleaved cell lymphoma View
stage IV grade I follicular small cleaved cell lymphoma View
stage IV grade II follicular mixed cell lymphoma View
stage IV adult diffuse small cleaved cell lymphoma View
recurrent grade I follicular small cleaved cell lymphoma View
recurrent grade II follicular mixed cell lymphoma View
recurrent grade III follicular large cell lymphoma View
recurrent adult diffuse small cleaved cell lymphoma View
recurrent adult diffuse mixed cell lymphoma View
recurrent adult diffuse large cell lymphoma View
recurrent adult immunoblastic large cell lymphoma View
recurrent adult lymphoblastic lymphoma View
recurrent adult diffuse small noncleaved cellBurkitts lymphoma View
prolymphocytic leukemia View
contiguous stage II grade I follicular small cleaved cell lymphoma View
contiguous stage II grade II follicular mixed cell lymphoma View
contiguous stage II adult diffuse small cleaved cell lymphoma View
noncontiguous stage II grade I follicular small cleaved cell lymphoma View
noncontiguous stage II grade II follicular mixed cell lymphoma View
noncontiguous stage II adult diffuse small cleaved cell lymphoma View
stage III diffuse small lymphocyticmarginal zone lymphoma View
contiguous stage II diffuse small lymphocyticmarginal zone lymphoma View
noncontiguous stage II diffuse small lymphocyticmarginal zone lymphoma View
stage IV diffuse small lymphocyticmarginal zone lymphoma View
recurrent diffuse small lymphocyticmarginal zone lymphoma View